Related Experiment Video
Updated: Nov 26, 2025
11:28
Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
Published on: April 28, 2015
10.6K
Achieving Ultrasmall Prussian Blue Nanoparticles as High-Performance Biomedical Agents with Multifunctions
Zhiguo Qin1, Bo Chen2, Yu Mao1
1State Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China.
ACS Applied Materials & Interfaces
|December 9, 2020
Summary
Researchers synthesized ultrasmall Prussian blue nanoparticles (USPBNPs) below 5 nm using an ethanol/water solvent and PVP capping agent. These USPBNPs exhibit enhanced catalytic activities and potential as T1 MRI contrast agents.
Area of Science:
- Nanotechnology
- Materials Science
- Biomedical Engineering
Background:
- Prussian blue nanoparticles (PBNPs) are vital iron-based metal-organic frameworks for biomedical applications.
- Achieving smaller PBNP sizes for enhanced functionality has been a significant challenge.
Purpose of the Study:
- To develop a method for synthesizing ultrasmall Prussian blue nanoparticles (USPBNPs) under 5 nm.
- To investigate the impact of synthesis parameters on PBNP size and properties.
- To evaluate the catalytic and MRI contrast agent potential of the synthesized USPBNPs.
Main Methods:
- Synthesis of PBNPs using an ethanol/water mixture as solvent.
- Utilizing polyvinyl pyrrolidone (PVP) as a surface capping agent to control particle size and prevent aggregation.
- Adjusting the ethanol/water ratio to control nucleation and particle growth.
- Characterization of USPBNP size, stability, catalytic activity, and longitudinal relaxation rate.
Main Results:
- Successfully synthesized highly stable ultrasmall PBNPs (USPBNPs) of approximately 3.4 nm at an ethanol/water ratio of 3:1.
- USPBNPs demonstrated significantly enhanced peroxidase-like and catalase-like activities compared to conventionally synthesized PBNPs.
- USPBNPs exhibited a high longitudinal relaxation rate (r1) of 1.3 mM⁻¹S⁻¹, indicating potential as T1 MRI contrast agents.
Conclusions:
- The developed method enables the controlled synthesis of sub-5 nm PBNPs.
- The resulting USPBNPs possess superior catalytic properties and hold promise for T1-weighted magnetic resonance imaging (MRI) applications.
